Tocris™ CCG 1423

Induces intermediate mesoderm differentiation from ESCs; Rho/SRF pathway inhibitor

Manufacturer: Tocris™ 5233/10

 View more versions of this product

Catalog No. 52-331-0

  Check Availability
Add to Cart


For Research Use Only


    Inhibitors CCG 1423
    Purity >99
    Molecular Weight 454.75
    Quantity 10mg
    Product Type CCG 1423

    Rho/SRF pathway inhibitor; stimulates apoptosis of a melanoma cell line overexpressing RhoC (A375M2). Suppresses Rho-dependent invasion of PC-3 prostate cancer cells in vitro and inhibits lysophosphatidic acid-induced DNA synthesis in PC-3 prostate cancer cells. When used in combination with Retinoic acid, LY 294002 and Pyridone 6, it induces intermediate mesoderm differentiation from ESCs.

    • Chemical Name: N-[2-[(4-Chlorophenyl)amino]-1-methyl-2-oxoethoxy]-3,5-bis(trifluoromethyl)benzamide
    • Formula: C18H13ClF6N2O3
    • CAS Number: 285986-88-1
    • Solubility: Soluble to 100mM in DMSO
    • Purity: >99

  • Description & Specifications

Related Products

Product Content Feedback

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit